Sanofi consumer unit attracting interest ahead of spinoff, Bloomberg says

Sanofiis working with Rothschild & Co. to start preparations for a planned separation of its consumer health division, which could be valued at more than $20B, Dinesh Nair, Swetha Gopinath, Michelle Davis and Ruth David of Bloomberg report, citing people with knowledge of the matter. The business has also attracted some initial interest from buyout firms that have been evaluating a potential acquisition, sources told Bloomberg. Sanofi could bring on more advisers for the spinoff at a later date, the people said.